SPCX Gives Back the Bond-Relief Bounce as Settlement Day Lands Without a Buyer

The Settlement-Day Fade

SPCX is back near $150.30, down 7.70% over the past 24 hours, and the path it took there is the whole story: the stock has round-tripped the entire relief bounce that carried it to roughly $162. The fuel for that bounce was SpaceX's first-ever bond issuance, a $25 billion deal that drew about $89 billion in orders — roughly 3.5x oversubscribed — and was set to settle June 26. That settlement is exactly the problem for the bounce. The bonds clear today, the proceeds repay the bridge loan, and the single most-anticipated bullish catalyst on the board is now spent. With nothing left to buy the rumor on, the tape sold the news and handed the move straight back.

The Bond Fixes Liquidity, Not Valuation

What the deal actually solved is narrow. The $20 billion bridge loan SpaceX raised in March carried a hard refinancing deadline, and that cliff — not Starship cadence or Starlink growth — was the structural fear that dragged the stock from $225 to $147.11 in three sessions, erasing more than $600 billion in market value. Spreading the refinance across maturities from 2031 to 2056 at coupons of 5.35% to 6.65% removes the deadline. It does nothing for the valuation. Morningstar still pegs fair value near $62, less than half the current quote, and even Susquehanna's Street-high $170 target sits on a Neutral rating. The credit market's appetite and the equity market's skepticism are pointing in opposite directions, and the equity side just reasserted itself.

What's Left to Trade

With the bond catalyst behind it, the next dated events on SPCX skew against the bulls. The December 2026 lockup expiration will free insider shares into a market that has shown it can't absorb supply at these multiples, and an S&P free-cash-flow outlook that stays negative through 2029 as xAI's operating losses compound gives valuation bears a multi-year runway. The level that matters is the $147.11 IPO-week low printed June 23; the round-trip back under $151 puts that floor directly in play, and a break below it would erase the last of the post-debut gains above the $135 IPO price. Until a fresh bull catalyst shows up, the burden of proof sits with the buyers.